How to Prevent RSV in Infants & Young Children, According to Experts

Health & Lifestyle
591

Listen to article (english)

Translate to Spanish or other 102 languages!

RSV infection can become serious in infants and young children, but there are ways to protect against severe illness. Image for illustration purposes
RSV infection can become serious in infants and young children, but there are ways to protect against severe illness. Image for illustration purposes

Mega Doctor News

- Advertisement -
  • Respiratory syncytial virus (RSV) is a common virus that may cause severe symptoms in infants, young children, and even older adults. 
  • RSV is the most common cause of infant hospitalizations in high-income countries. 
  • In 2019, about 1.4 million infants ages 0–6 months globally were hospitalized for episodes of RSV-associated acute lower respiratory infection. 
  • RSV infection can become serious, but there are ways to protect infants and young children from severe illness.

Respiratory syncytial virus (RSV) commonly presents with cold-like symptoms, such as a runny nose and cough.

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/rsv-prevention-infants-young-children

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
What Do You Know About Pancreatitis?
Next article
The Top 5 Most Googled Injuries in Texas

More Articles

New Strategy Helps Immune System Fight High‑Grade Ovarian Cancer

Researchers at the University of California San Diego and collaborators have discovered a new way to help the immune system fight ovarian cancer by changing how tumors communicate with nearby immune cells.

Study Highlights Dangers of Alcohol Use and Risk for Colorectal Cancer

Mega Doctor News CLEVELAND CLINIC - Research continues to show the negative impact...

Researchers Uncover Why Colorectal Tumors Rely on Sugar to Grow

Despite advances in surgery and therapies, patients with metastatic colorectal cancer continue to have poor outcomes, highlighting the need for novel treatments.

Cedars‑Sinai Develops AI Platform to Guide Pancreatic Cancer Treatment Choices

A new tool co-developed by investigators from Cedars-Sinai Health Sciences University can predict which of two available chemotherapy options for pancreatic cancer would be more effective for an individual patient.
- Advertisement -